Retnia is a Canadian company that provides innovative, non-invasive ocular oximetry tools to researchers and eye-care professionals.
Retnia has developed a patented, non-invasive device to accurately measure the concentration of oxygen in the human eye. This unique and revolutionary technology is the fruit of more than 15 years of research.
The technology enables researchers and eye-care professionals to gain insight into pathophysiological and metabolic processes. It offers applications for screening, diagnosing, monitoring, and managing the care of diseases such as glaucoma, diabetic retinopathy and age-related macular degeneration.
Using light to provide crucial information on the health of ocular tissues and processes involved in ocular diseases.
Quantitative, non invasive, continuous, real time, full light spectrum analysis for ocular oximetry.
Revolutionize the way we prevent, screen, diagnose and treat patients with ocular diseases.
Retnia’s technology is based on a patented instrument coupled with a unique software to accurately measure, non-invasively and in real-time, the concentration of oxygen in the human eye. Light reflects on the eye fundus and is analyzed to provide accurate measurements which are then clearly presented in a user-friendly environment.